{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:01:12Z","timestamp":1792800072920,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:00:00Z","timestamp":1625875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:00:00Z","timestamp":1625875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Asociaci\u00f3n S\u00edndrome Phelan-McDermid Espa\u00f1a"},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI18\/00233"],"award-info":[{"award-number":["FI18\/00233"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI17\/00819"],"award-info":[{"award-number":["FIS PI17\/00819"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CIBERSAM, Madrid Regional Government","award":["B2017\/BMD-3740 AGES-CM-2"],"award-info":[{"award-number":["B2017\/BMD-3740 AGES-CM-2"]}]},{"name":"European Union Structural Funds","id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"crossref"}]},{"name":"European Union Seventh Framework Program","id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"crossref"}]},{"name":"European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking","award":["115916, Project PRISM"],"award-info":[{"award-number":["115916, Project PRISM"]}],"id":[{"id":"https:\/\/ror.org\/019af4n30","id-type":"ROR","asserted-by":"crossref"}]},{"name":"European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking","award":["777394, Project AIMS-2-TRIALS"],"award-info":[{"award-number":["777394, Project AIMS-2-TRIALS"]}],"id":[{"id":"https:\/\/ror.org\/019af4n30","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Fundaci\u00f3n Familia Alonso"},{"DOI":"10.13039\/100008062","name":"Fundaci\u00f3n Alicia Koplowitz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008061","name":"Fundaci\u00f3n Mutua Madrile\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurodevelop Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Phelan-McDermid syndrome (PMS) is a rare genetic disorder compromising the 22q13 terminal region and affecting\n                      <jats:italic>SHANK3<\/jats:italic>\n                      , a gene crucial to the neurobehavioural phenotype and strongly linked to autism (ASD) and intellectual disability (ID). The condition is characterised by global developmental delay, ID, speech impairments, hypotonia and autistic behaviours, although its presentation and symptom severity vary widely. In this study, we provide a thorough description of the behavioural profile in PMS and explore differences related to deletion size and language ability.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used standard clinical assessment instruments to measure altered behaviour, adaptive skills and autistic symptomatology in sixty participants with PMS (30 females, median age 8.5 years, SD=7.1). We recorded background information and other clinical manifestations and explored associations with deletion size. We performed descriptive and inferential analyses for group comparison.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found delayed gross and fine motor development, delayed and impaired language (~70% of participants non or minimally verbal), ID of different degrees and adaptive functioning ranging from severe to borderline impairment. Approximately 40% of participants experienced developmental regression, and half of those regained skills. Autistic symptoms were frequent and variable in severity, with a median ADOS-2 CSS score of 6 for every domain. Sensory processing anomalies, hyperactivity, attentional problems and medical comorbidities were commonplace. The degree of language and motor development appeared to be associated with deletion size.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study adds to previous research on the clinical descriptions of PMS and supports results suggesting wide variability of symptom severity and its association with deletion size. It makes the case for suitable psychotherapeutic and pharmacological approaches, for longitudinal studies to strengthen our understanding of possible clinical courses and for more precise genomic analysis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s11689-021-09370-5","type":"journal-article","created":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T07:02:43Z","timestamp":1625900563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Characterisation of the clinical phenotype in Phelan-McDermid syndrome"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4252-0373","authenticated-orcid":false,"given":"M\u00f3nica","family":"Burdeus-Olavarrieta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"San Jos\u00e9-C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Garc\u00eda-Alc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Gonz\u00e1lez-Pe\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Hern\u00e1ndez-Jusdado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Parellada-Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,10]]},"reference":[{"issue":"5","key":"9370_CR1","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/ajmg.1320430524","volume":"43","author":"MC Phelan","year":"1992","unstructured":"Phelan MC, Thomas GR, Saul RA, Rogers RC, Taylor HA, Wenger DA, et al. Cytogenetic, biochemical, and molecular analyses of a 22q13 deletion. Am J Med Genet. 1992;43(5):872\u20136. https:\/\/doi.org\/10.1002\/ajmg.1320430524.","journal-title":"Am J Med Genet"},{"issue":"3-5","key":"9370_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000334260","volume":"2","author":"K Phelan","year":"2011","unstructured":"Phelan K, McDermid H. The 22q13. 3 deletion syndrome (Phelan-McDermid syndrome). Molecular syndromology. 2011;2(3-5):186\u2013201. https:\/\/doi.org\/10.1159\/000334260.","journal-title":"Molecular syndromology"},{"issue":"1","key":"9370_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13229-018-0205-9","volume":"9","author":"S De Rubeis","year":"2018","unstructured":"De Rubeis S, Siper PM, Durkin A, Weissman J, Muratet F, Halpern D, et al. Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations. Molecular autism. 2018;9(1):31. https:\/\/doi.org\/10.1186\/s13229-018-0205-9.","journal-title":"Molecular autism"},{"issue":"7","key":"9370_CR4","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00439-014-1423-7","volume":"133","author":"SM Sarasua","year":"2014","unstructured":"Sarasua SM, Boccuto L, Sharp JL, Dwivedi A, Chen C-F, Rollins JD, et al. Clinical and genomic evaluation of 201 patients with Phelan\u2013McDermid syndrome. Hum Genet. 2014;133(7):847\u201359. https:\/\/doi.org\/10.1007\/s00439-014-1423-7.","journal-title":"Hum Genet"},{"issue":"1","key":"9370_CR5","first-page":"1","volume":"5","author":"M Yitzchak Frank","year":"2017","unstructured":"Yitzchak Frank M, Jamison JM, Tavassoli T, Kolevzon M. A prospective study of neurological abnormalities in Phelan-McDermid syndrome. Journal of Rare Disorders. 2017;5(1):1.","journal-title":"Journal of Rare Disorders"},{"issue":"1","key":"9370_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000339119","volume":"3","author":"A Denayer","year":"2012","unstructured":"Denayer A, Van Esch H, De Ravel T, Frijns J-P, Van Buggenhout G, Vogels A, et al. Neuropsychopathology in 7 patients with the 22q13 deletion syndrome: presence of bipolar disorder and progressive loss of skills. Molecular syndromology. 2012;3(1):14\u201320. https:\/\/doi.org\/10.1159\/000339119.","journal-title":"Molecular syndromology"},{"key":"9370_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jpsychires.2017.03.010","volume":"91","author":"G Reierson","year":"2017","unstructured":"Reierson G, Bernstein J, Froehlich-Santino W, Urban A, Purmann C, Berquist S, et al. Characterizing regression in Phelan McDermid Syndrome (22q13 deletion syndrome). J Psychiatr Res. 2017;91:139\u201344. https:\/\/doi.org\/10.1016\/j.jpsychires.2017.03.010.","journal-title":"J Psychiatr Res"},{"key":"9370_CR8","volume-title":"SHANK3 haploinsufficiency: a \u201ccommon\u201d but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders","author":"C Betancur","year":"2013","unstructured":"Betancur C, Buxbaum JD. SHANK3 haploinsufficiency: a \u201ccommon\u201d but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders: BioMed Central; 2013."},{"issue":"1","key":"9370_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s11689-016-9150-0","volume":"8","author":"RJ Zwanenburg","year":"2016","unstructured":"Zwanenburg RJ, Ruiter SA, van den Heuvel ER, Flapper BC, Van Ravenswaaij-Arts CM. Developmental phenotype in Phelan-McDermid (22q13. 3 deletion) syndrome: a systematic and prospective study in 34 children. J Neurodev Disord. 2016;8(1):16.","journal-title":"J Neurodev Disord"},{"issue":"2","key":"9370_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/dneu.22128","volume":"74","author":"A Guilmatre","year":"2014","unstructured":"Guilmatre A, Huguet G, Delorme R, Bourgeron T. The emerging role of SHANK genes in neuropsychiatric disorders. Developmental neurobiology. 2014;74(2):113\u201322. https:\/\/doi.org\/10.1002\/dneu.22128.","journal-title":"Developmental neurobiology"},{"issue":"9","key":"9370_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004580","volume":"10","author":"CS Leblond","year":"2014","unstructured":"Leblond CS, Nava C, Polge A, Gauthier J, Huguet G, Lumbroso S, et al. Meta-analysis of SHANK mutations in autism spectrum disorders: a gradient of severity in cognitive impairments. PLoS Genet. 2014;10(9):e1004580. https:\/\/doi.org\/10.1371\/journal.pgen.1004580.","journal-title":"PLoS Genet"},{"issue":"2","key":"9370_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.conb.2009.06.003","volume":"19","author":"T Bourgeron","year":"2009","unstructured":"Bourgeron T. A synaptic trek to autism. Curr Opin Neurobiol. 2009;19(2):231\u20134. https:\/\/doi.org\/10.1016\/j.conb.2009.06.003.","journal-title":"Curr Opin Neurobiol"},{"issue":"8","key":"9370_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/jmg.40.8.575","volume":"40","author":"H Wilson","year":"2003","unstructured":"Wilson H, Wong A, Shaw S, Tse W, Stapleton G, Phelan M, et al. Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3\/PROSAP2 in the major neurological symptoms. J Med Genet. 2003;40(8):575\u201384. https:\/\/doi.org\/10.1136\/jmg.40.8.575.","journal-title":"J Med Genet"},{"issue":"1","key":"9370_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2040-2392-4-18","volume":"4","author":"L Soorya","year":"2013","unstructured":"Soorya L, Kolevzon A, Zweifach J, Lim T, Dobry Y, Schwartz L, et al. Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency. Molecular autism. 2013;4(1):18. https:\/\/doi.org\/10.1186\/2040-2392-4-18.","journal-title":"Molecular autism"},{"issue":"9","key":"9370_CR15","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ng.909","volume":"43","author":"GM Cooper","year":"2011","unstructured":"Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, et al. A copy number variation morbidity map of developmental delay. Nat Genet. 2011;43(9):838\u201346. https:\/\/doi.org\/10.1038\/ng.909.","journal-title":"Nat Genet"},{"issue":"4","key":"9370_CR16","doi-asserted-by":"publisher","first-page":"e34739","DOI":"10.1371\/journal.pone.0034739","volume":"7","author":"X Gong","year":"2012","unstructured":"Gong X, Jiang Y-W, Zhang X, An Y, Zhang J, Wu Y, et al. High proportion of 22q13 deletions and SHANK3 mutations in Chinese patients with intellectual disability. PLoS One. 2012;7(4):e34739.","journal-title":"PLoS One"},{"issue":"1","key":"9370_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41525-017-0035-2","volume":"2","author":"A-C Tabet","year":"2017","unstructured":"Tabet A-C, Rolland T, Ducloy M, L\u00e9vy J, Buratti J, Mathieu A, et al. A framework to identify contributing genes in patients with Phelan-McDermid syndrome. NPJ genomic medicine. 2017;2(1):32. https:\/\/doi.org\/10.1038\/s41525-017-0035-2.","journal-title":"NPJ genomic medicine"},{"issue":"11","key":"9370_CR18","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/jmedgenet-2011-100225","volume":"48","author":"SM Sarasua","year":"2011","unstructured":"Sarasua SM, Dwivedi A, Boccuto L, Rollins JD, Chen C-F, Rogers RC, et al. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan\u2013McDermid syndrome (22q13 deletion syndrome). J Med Genet. 2011;48(11):761\u20136. https:\/\/doi.org\/10.1136\/jmedgenet-2011-100225.","journal-title":"J Med Genet"},{"issue":"1","key":"9370_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13023-015-0323-9","volume":"10","author":"LM Oberman","year":"2015","unstructured":"Oberman LM, Boccuto L, Cascio L, Sarasua S, Kaufmann WE. Autism spectrum disorder in Phelan-McDermid syndrome: initial characterization and genotype-phenotype correlations. Orphanet journal of rare diseases. 2015;10(1):105. https:\/\/doi.org\/10.1186\/s13023-015-0323-9.","journal-title":"Orphanet journal of rare diseases"},{"issue":"4","key":"9370_CR20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/gim.2013.144","volume":"16","author":"SM Sarasua","year":"2014","unstructured":"Sarasua SM, Dwivedi A, Boccuto L, Chen C-F, Sharp JL, Rollins JD, et al. 22q13. 2q13. 32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan\u2013McDermid syndrome. Genetics in Medicine. 2014;16(4):318.","journal-title":"Genetics in Medicine"},{"issue":"2","key":"9370_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.eurpsy.2011.06.004","volume":"28","author":"M Parellada","year":"2013","unstructured":"Parellada M, Boada L, Moreno C, Llorente C, Romo J, Muela C, et al. Specialty care programme for autism spectrum disorders in an urban population: a case-management model for health care delivery in an ASD population. European Psychiatry. 2013;28(2):102\u20139. https:\/\/doi.org\/10.1016\/j.eurpsy.2011.06.004.","journal-title":"European Psychiatry"},{"key":"9370_CR22","volume-title":"ADOS-2. Escala de Observaci\u00f3n para el Diagn\u00f3stico del Autismo-2 Manual (T Luque, adaptadora)","author":"C Lord","year":"2015","unstructured":"Lord C, Rutter M, DiLavore P, Risi S, Gotham K, Bishop S, et al. ADOS-2. Escala de Observaci\u00f3n para el Diagn\u00f3stico del Autismo-2 Manual (T Luque, adaptadora). Madrid: TEA Ediciones; 2015."},{"key":"9370_CR23","volume-title":"ADI-R: Entrevista para el diagn\u00f3stico del autismo-revisada: TEA","author":"M Rutter","year":"2006","unstructured":"Rutter M, Le Couteur A, Lord C. ADI-R: Entrevista para el diagn\u00f3stico del autismo-revisada: TEA; 2006."},{"key":"9370_CR24","doi-asserted-by":"publisher","unstructured":"Phelan MC, Rogers RC, Saul RA, Stapleton GA, Sweet K, McDermid H, et al. 22q13 deletion syndrome. Am J Med Genet. 2001;101(2):91\u20139. https:\/\/doi.org\/10.1002\/1096-8628(20010615)101:2%3C91::AID-AJMG1340%3E3.0.CO;2-C.","DOI":"10.1002\/1096-8628(20010615)101:2%3C91::AID-AJMG1340%3E3.0.CO;2-C"},{"issue":"4","key":"9370_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1023\/A:1025014929212","volume":"33","author":"JN Constantino","year":"2003","unstructured":"Constantino JN, Davis SA, Todd RD, Schindler MK, Gross MM, Brophy SL, et al. Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised. J Autism Dev Disord. 2003;33(4):427\u201333. https:\/\/doi.org\/10.1023\/A:1025014929212.","journal-title":"J Autism Dev Disord"},{"key":"9370_CR26","volume-title":"Sensory profile 2: Psych Corporation","author":"W Dunn","year":"2014","unstructured":"Dunn W. Sensory profile 2: Psych Corporation; 2014."},{"issue":"5","key":"9370_CR27","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s10803-008-0674-3","volume":"39","author":"K Gotham","year":"2009","unstructured":"Gotham K, Pickles A, Lord C. Standardizing ADOS scores for a measure of severity in autism spectrum disorders. J Autism Dev Disord. 2009;39(5):693\u2013705. https:\/\/doi.org\/10.1007\/s10803-008-0674-3.","journal-title":"J Autism Dev Disord"},{"issue":"5","key":"9370_CR28","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.ridd.2013.01.028","volume":"34","author":"T Sappok","year":"2013","unstructured":"Sappok T, Diefenbacher A, Budczies J, Schade C, Grubich C, Bergmann T, et al. Diagnosing autism in a clinical sample of adults with intellectual disabilities: how useful are the ADOS and the ADI-R? Res Dev Disabil. 2013;34(5):1642\u201355. https:\/\/doi.org\/10.1016\/j.ridd.2013.01.028.","journal-title":"Res Dev Disabil"},{"key":"9370_CR29","volume-title":"Vineland adaptive behavior scales, (Vineland-3)","author":"S Sparrow","year":"2016","unstructured":"Sparrow S, Cicchetti DV, Saulnier CA. Vineland adaptive behavior scales, (Vineland-3). Antonio: Psychological Corporation; 2016."},{"key":"9370_CR30","unstructured":"Aman MG, Burrow WH, Wolford PL. The Aberrant Behavior Checklist-Community: factor validity and effect of subject variables for adults in group homes. Am J Ment Retard. 1995."},{"key":"9370_CR31","unstructured":"Achenbach T, Rescorla L. Manual for the ASEBA school-age forms & profiles: an integrated system of multi-informant assessment Burlington, VT: University of Vermont. Research Center for Children, Youth, & Families. 2001;1617."},{"issue":"5","key":"9370_CR32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1469-7610.1997.tb01545.x","volume":"38","author":"R Goodman","year":"1997","unstructured":"Goodman R. The Strengths and Difficulties Questionnaire: a research note. J Child Psychol Psychiatry. 1997;38(5):581\u20136. https:\/\/doi.org\/10.1111\/j.1469-7610.1997.tb01545.x.","journal-title":"J Child Psychol Psychiatry"},{"issue":"5","key":"9370_CR33","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1532-5415.1968.tb02103.x","volume":"16","author":"BS Linn","year":"1968","unstructured":"Linn BS, LINN MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968;16(5):622\u20136. https:\/\/doi.org\/10.1111\/j.1532-5415.1968.tb02103.x.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"9370_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"key":"9370_CR35","volume-title":"PASW statistics 18","author":"SPSS I","year":"2009","unstructured":"SPSS I. PASW statistics 18. Chicago: SPSS Inc.; 2009."},{"key":"9370_CR36","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2020","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2020."},{"issue":"1","key":"9370_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s11689-019-9273-1","volume":"11","author":"CI Samogy-Costa","year":"2019","unstructured":"Samogy-Costa CI, Varella-Branco E, Monfardini F, Ferraz H, Fock RA, Barbosa RHA, et al. A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case. J Neurodev Disord. 2019;11(1):13. https:\/\/doi.org\/10.1186\/s11689-019-9273-1.","journal-title":"J Neurodev Disord"},{"issue":"2","key":"9370_CR38","doi-asserted-by":"publisher","first-page":"e376","DOI":"10.1542\/peds.2007-2584","volume":"122","author":"A Philippe","year":"2008","unstructured":"Philippe A, Boddaert N, Vaivre-Douret L, Robel L, Danon-Boileau L, Malan V, et al. Neurobehavioral profile and brain imaging study of the 22q13. 3 deletion syndrome in childhood. Pediatrics. 2008;122(2):e376\u2013e82. https:\/\/doi.org\/10.1542\/peds.2007-2584.","journal-title":"Pediatrics."},{"issue":"1","key":"9370_CR39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41398-018-0212-9","volume":"8","author":"L Ponson","year":"2018","unstructured":"Ponson L, Gomot M, Blanc R, Barthelemy C, Roux S, Munnich A, et al. 22q13 deletion syndrome: communication disorder or autism? Evidence from a specific clinical and neurophysiological phenotype. Transl Psychiatry. 2018;8(1):146. https:\/\/doi.org\/10.1038\/s41398-018-0212-9.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"9370_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1017\/S0954579409990265","volume":"22","author":"J Richler","year":"2010","unstructured":"Richler J, Huerta M, Bishop SL, Lord C. Developmental trajectories of restricted and repetitive behaviors and interests in children with autism spectrum disorders. Dev Psychopathol. 2010;22(1):55\u201369. https:\/\/doi.org\/10.1017\/S0954579409990265.","journal-title":"Dev Psychopathol"},{"key":"9370_CR41","doi-asserted-by":"publisher","unstructured":"Thurm A, Farmer C, Salzman E, Lord C, Bishop S. State of the field: Differentiating intellectual disability from autism spectrum disorder. Frontiers in psychiatry. 2019;10. https:\/\/doi.org\/10.3389\/fpsyt.2019.00526.","DOI":"10.3389\/fpsyt.2019.00526"},{"issue":"4","key":"9370_CR42","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/gbb.12285","volume":"15","author":"J Egger","year":"2016","unstructured":"Egger J, Zwanenburg R, van Ravenswaaij-Arts C, Kleefstra T, Verhoeven W. Neuropsychological phenotype and psychopathology in seven adult patients with Phelan-McDermid syndrome: implications for treatment strategy. Genes Brain Behav. 2016;15(4):395\u2013404. https:\/\/doi.org\/10.1111\/gbb.12285.","journal-title":"Genes Brain Behav"},{"issue":"1","key":"9370_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13229-019-0291-3","volume":"10","author":"A Kolevzon","year":"2019","unstructured":"Kolevzon A, Delaby E, Berry-Kravis E, Buxbaum JD, Betancur C. Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature. Molecular Autism. 2019;10(1):1\u201322.","journal-title":"Molecular Autism"},{"issue":"1","key":"9370_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1866-1955-6-39","volume":"6","author":"A Kolevzon","year":"2014","unstructured":"Kolevzon A, Angarita B, Bush L, Wang AT, Frank Y, Yang A, et al. Phelan-McDermid syndrome: a review of the literature and practice parameters for medical assessment and monitoring. J Neurodev Disord. 2014;6(1):39. https:\/\/doi.org\/10.1186\/1866-1955-6-39.","journal-title":"J Neurodev Disord"},{"issue":"7","key":"9370_CR45","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1080\/13854046.2017.1413211","volume":"32","author":"L Soorya","year":"2018","unstructured":"Soorya L, Leon J, Trelles MP, Thurm A. Framework for assessing individuals with rare genetic disorders associated with profound intellectual and multiple disabilities (PIMD): the example of Phelan McDermid syndrome. Clin Neuropsychol. 2018;32(7):1226\u201355. https:\/\/doi.org\/10.1080\/13854046.2017.1413211.","journal-title":"Clin Neuropsychol"},{"issue":"4","key":"9370_CR46","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10803-006-0280-1","volume":"37","author":"K Gotham","year":"2007","unstructured":"Gotham K, Risi S, Pickles A, Lord C. The Autism Diagnostic Observation Schedule: revised algorithms for improved diagnostic validity. J Autism Dev Disord. 2007;37(4):613\u201327. https:\/\/doi.org\/10.1007\/s10803-006-0280-1.","journal-title":"J Autism Dev Disord"}],"container-title":["Journal of Neurodevelopmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-021-09370-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11689-021-09370-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-021-09370-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T07:03:12Z","timestamp":1625900592000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneurodevdisorders.biomedcentral.com\/articles\/10.1186\/s11689-021-09370-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,10]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["9370"],"URL":"https:\/\/doi.org\/10.1186\/s11689-021-09370-5","relation":{},"ISSN":["1866-1947","1866-1955"],"issn-type":[{"value":"1866-1947","type":"print"},{"value":"1866-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,10]]},"assertion":[{"value":"23 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Caregivers gave informed consent in all cases (all adult participants were legally incapacitated). The ethics committee of the Hospital General Universitario Gregorio Mara\u00f1\u00f3n approved the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AGA, JGP and PHJ declare that they have no competing interests. MBO received salary for the study coordination and data collection from Asociaci\u00f3n S\u00edndrome Phelan-McDermid Espa\u00f1a. ASJC has been a consultant for F. Hoffmann-La Roche Ltd, consults for Servier and is involved in clinical trials conducted by Servier. The present work is unrelated to the above grants and relationships. MPR has been a consultant for Fundaci\u00f3n Alicia Koplowitz, the EMA and Instituto de Salud Carlos III (ISCIII); consults for Servier and Exeltis; has received grant\/research support from CIBERSAM, Fundaci\u00f3n Alicia Koplowitz, Fundaci\u00f3n Mutua Madrile\u00f1a, ISCIII and Horizon2020; receives travel support from Exeltis; and is involved in clinical trials conducted by Servier, F. Hoffmann-La Roche Ltd and Horizon2020. The present work is unrelated to the above grants and relationships.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}